Appili Therapeutics Inc. announced that one of its Directors, Rochelle Stenzler, has passed away. The Company plans on seeking a new independent Director to join its Board in the coming months.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.04 CAD | 0.00% |
|
0.00% | +14.29% |
26/06 | Appili Therapeutics Q4 Loss Narrows Amid Increase in Government Assistance | MT |
26/06 | Appili Therapeutics Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+14.29% | 3.54M | |
+15.20% | 122B | |
+19.67% | 113B | |
+18.95% | 26.49B | |
-23.86% | 19.4B | |
-19.03% | 16.24B | |
-20.90% | 15.4B | |
-46.14% | 15.15B | |
+63.85% | 14.93B | |
+4.49% | 13.52B |
- Stock Market
- Equities
- APLI Stock
- News Appili Therapeutics Inc.
- Appili Therapeutics Inc. Announces Demise of Rochelle Stenzler, as the Director of the Company